Quan, Victor L.
Erickson, Taylor
Daftary, Karishma
Chovatiya, Raj http://orcid.org/0000-0001-6510-399X
Funding for this research was provided by:
Foundation for the National Institutes of Health (K12 HS026385)
Article History
Accepted: 23 May 2023
First Online: 19 June 2023
Declarations
:
: RC received funding from NIH Grant Number K12 HS026385.
: RC has served as an advisory board member, consultant, speaker, and/or investigator for AbbVie, Apogee, Arcutis, Argenx, ASLAN, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, Eli Lilly and Company, Galderma, Genentech, Incyte, LEO Pharma, L’Oréal, Novan, Inc., Pfizer Inc., Regeneron, Sanofi, and UCB. VQ, TE, and KD have no conflicts to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: R Chovatiya had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis. Study concept and design: R Chovatiya. Acquisition of data: VL Quan, T Erickson, K Daftary, R Chovatiya. Analysis and interpretation of data: VL Quan, T Erickson, K Daftary, R Chovatiya. Drafting of the manuscript: VL Quan, T Erickson, K Daftary, R Chovatiya. Critical revision of the manuscript for important intellectual content: VL Quan, T Erickson, K Daftary, R Chovatiya. All authors read and approved the final manuscript.